Condition: Atrial Fibrillation · Sponsor: Medtronic Cardiac Ablation Solutions
The PulseSelect™ PFA Global Registry is a prospective, global, multi-center, observational post-approval study. Subjects will be treated with the PulseSelect™ PFA System and followed according to SOC.
This description comes directly from the study's public registry record.
Josman Suri · 7635050262 · josman.suri@medtronic.com
Always discuss trial participation with your own doctor first.
| Vancouver General Hospital | Vancouver, British Columbia, Canada | Recruiting |
| McGill University Health Centre (MUHC) | Montreal, Quebec, Canada | Recruiting |
| Fuwai Hospital Chinese Academy of Medical Sciences | Beijing, China | Recruiting |
| Fujian Provincial Hospital | Fuzhou, China | Recruiting |
| The Second Affiliated Hospital of Harbin Medical University | Harbin, China | Recruiting |
| Nanjing Drum Tower Hospital | Nanjing, China | Recruiting |
| Ruijin Hospital Shanghai Jiao Tong University School of Medicine | Shanghai, China | Recruiting |
| Fuwai Shenzhen Hospital Chinese Academy of Medical Sciences | Shenzhen, China | Recruiting |
| The First Affiliated Hospital of Xinjiang Medical University | Ürümqi, China | Recruiting |
| Wuhan Asia General Hospital | Wuhan, China | Recruiting |
| The First Affiliated Hospital of Xiamen University | Xiamen, China | Recruiting |
| Klinička Bolnica Dubrava | Zagreb, Croatia | Recruiting |
+ 25 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06393920